Pulmonary Artery Hypertension Clinical Trial
Official title:
Impact of Aerobic Training on Sleep Quality and Aerobic Fitness in Male Patients With Pulmonary Artery Hypertension: a Randomized Control Study
This study investigated the effect of 12 weeks of aerobic training on sleep quality and aerobic fitness in patients with Pulmonary arterial hypertension(PAH).
Thirty male PAH patients were included in the study. They were randomized into two equal groups; Training group (A) and Control group(B). Right ventricular systolic pressure (RVSP) measured using Doppler Echocardiography , Pittsburg sleep quality index (PSQI) questionnaire with the wrist worn actigraph used for the assessment of sleep disturbance, and Cardiopulmonary exercise testing (CPET) measurements included maximal heart rate and VO2max .All were measured before and after the study period for both groups.The training was a moderate intensity aerobic training on a bicycle ergometer (corresponding to 60% to 70% of the maximal heart rate they reach during peak oxygen uptake in the initial exercise test) for 30 to 45 min/day, 3 sessions/week for 12 weeks (36 sessions). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05056532 -
Evaluation of Respiratory Muscle in Patient With Pulmonary Arterial Hypertension
|
||
Active, not recruiting |
NCT06003244 -
High Altitude (HA) Residents With Pulmonary Vascular Diseases (PVD), 6 Minute Walk Distance (6MWD) Assessed at 2840m (HA) With and Without Supplemental Oxygen Therapy (SOT)
|
N/A | |
Active, not recruiting |
NCT06072417 -
HA Residents With PVD, SDB Assessed at HA (2840m) vs LA (Sea Level)
|
N/A | |
Recruiting |
NCT02966665 -
: Vascular Function in Health and Disease
|
Phase 1 | |
Recruiting |
NCT00502398 -
Is There Intravascular Hemolysis in Patients With Pulmonary Hypertension?
|
N/A | |
Completed |
NCT04456998 -
GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH)
|
Phase 2 | |
Not yet recruiting |
NCT06035861 -
Endothelial Cell Activation and Total Pulmonary Resistance in PAH
|
N/A | |
Recruiting |
NCT03138863 -
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)
|
N/A | |
Recruiting |
NCT02102672 -
Trimetazidine in Pulmonary Artery Hypertension
|
Phase 2 | |
Withdrawn |
NCT06122922 -
Xenon MRI in Stable Pulmonary Hypertension (Jupiter AUGEAN)
|
Phase 2 | |
Recruiting |
NCT03195543 -
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
|
||
Completed |
NCT03198910 -
Retrospective Data Analysis of Data From the Zurich PH Registry
|
||
Completed |
NCT03979482 -
Skeletal Muscle Mitochondrial Abnormalities and the Metabolic Syndrome in PAH
|
||
Active, not recruiting |
NCT06084559 -
HA Residents With PVD, Pulmonary Artery Pressure (PAP) Assessed at HA (2840m) With and Without Supplemental Oxygen Therapy (SOT)
|
N/A | |
Active, not recruiting |
NCT05996302 -
HA Residents With PVD, 6MWD Assessed at HA (2840m) vs LA (Sea Level)
|
N/A | |
Withdrawn |
NCT02684786 -
A Study of Stellate Ganglion Block and / or Reserpine in Group 2 Pulmonary Hypertension
|
Phase 1 | |
Not yet recruiting |
NCT06258850 -
REstoration of VItamin D in Pulmonary Arterial Hypertension
|
Phase 4 | |
Completed |
NCT04094272 -
Pulmonary Arterial Hypertension in Patients With Direct-Acting Antiviral Medications for Hepatitis C Virus Infection
|
||
Active, not recruiting |
NCT01763112 -
Training With Whole Body Vibration Device in Patients With PAH
|
N/A | |
Completed |
NCT01581086 -
Vascular Subphenotypes of Lung Disease in HIV & COPD
|
N/A |